All In MedTech

Device Trial Radar · NCT04737421

A Clinical Study on Implants With TiUltra Technology and Associated Prosthetic Components

A Prospective, Non-interventional, Clinical Study to Evaluate the Safety, Performance and Clinical Benefits of Implants With TiUltra Technology and Associated Prosthetic Components

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

1,000

Actual

Start

May 26, 2021

Primary completion

May 31, 2029

Study completion May 31, 2029

Sponsor

Lead sponsor
Nobel BiocareNot on our public-company list
Sponsor type
Industry
First posted
Feb 3, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years

Summary

As written by the sponsor on the registry.

This is a multicenter, prospective, non-interventional study in which a total of 1000 subjects in need of a single, multiple or full arch restoration in any region of the mouth (healed or extracted) will be treated in up to 30 study centers. The primary aim of this study is to demonstrate non-inferiority of all NobelBiocare TiUltra implants to historic data from NobelActive TiUnite coated implant in terms of marginal bone level change over 5 years after final prosthetic delivery. Eligible subjects who provide their informed consent for participation will be enrolled into one of four groups, each sized to 250 individuals. They will be treated with the corresponding implant system assigned to the group. The allocation into a certain group is only driven by the subject's clinical and restorative requirement and standard of care at the enrolling study clinic. Each subject will be followed for 5 years after definitive prosthetic placement

Conditions

  • Marginal Bone Level Change

Interventions

  • NobelActive TiUltra implantDevice

    Subjects will be enrolled and treated with one of the above groups as per the their clinical requirement and standard of care of the clinic.

  • NobelParallel CC TiUltra implantsDevice

    Subjects will be enrolled and treated with one of the above groups as per the their clinical requirement and standard of care of the clinic.

  • NobelReplace CC TiUltra implantsDevice

    Subjects will be enrolled and treated with one of the above groups as per the their clinical requirement and standard of care of the clinic.

  • Nobel Biocare N1 TiUltra TCC implantsDevice

    Subjects will be enrolled and treated with one of the above groups as per the their clinical requirement and standard of care of the clinic.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Marginal bone level changeTime frame: Definitive prosthetic delivery to 5-years follow-up

Locations

32 sites in 14 countries. Site status is shown where the registry gives one.

  • Madison Prosthodontics

    Madison, Alabama

31 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.